Literature DB >> 19028640

Surgery as early revascularization after acute myocardial infarction.

Senol Yavuz1.   

Abstract

Acute myocardial infarction (AMI) is the leading cause of morbidity and mortality in most industrialized nations throughout the world. Options for myocardial revascularization include thrombolysis or percutaneous coronary intervention (PCI) in the early period after AMI, or coronary artery bypass grafting (CABG) for suitable patients. It has commonly been suggested that surgery in the early period after AMI can be associated with increased morbidity and mortality. However, advances in technology, surgical methods and myocardial protection techniques currently provide a chance for cardiovascular surgeon to achieve CABG in the setting of AMI. In patients with AMI, interest in early surgical revascularization has decreased with widespread use of thrombolytics or PCI. However, early surgical revascularization is beneficial in patients who have mechanical complications, ongoing ischemia, and cardiogenic shock complicating AMI. Failure of thrombolytic agents, unsuccessful PCI or left main coronary artery disease also requires surgery. Theoretically, early surgical revascularization may be useful by minimizing infarct size improving left ventricular function, and increasing patient survival. The optimal timing of surgery after AMI remains undecided as a controversial subject. It ranges from immediate surgical intervention to surgery 30 days after myocardial infarction. Therefore, such a wide variation in the therapeutic strategy of the surgical groups has made way a selection bias in these patients. This review presented highlights optimal timing of surgical revascularization after AMI, surgical methods and controlled reperfusion, risk factors for poor outcomes after surgery for AMI, and the role of surgery in patients with AMI complicated by cardiogenic shock.

Entities:  

Mesh:

Year:  2008        PMID: 19028640

Source DB:  PubMed          Journal:  Anadolu Kardiyol Derg        ISSN: 1302-8723


  8 in total

1.  eComment. Early coronary artery bypass surgery for acute non-ST elevation myocardial infarction.

Authors:  Senol Yavuz; Cuneyt Eris
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07

2.  Oxidation of ryanodine receptor after ischemia-reperfusion increases propensity of Ca2+ waves during β-adrenergic receptor stimulation.

Authors:  Elisa Bovo; Stefan R Mazurek; Aleksey V Zima
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-20       Impact factor: 4.733

Review 3.  Functional Impact of Ryanodine Receptor Oxidation on Intracellular Calcium Regulation in the Heart.

Authors:  Aleksey V Zima; Stefan R Mazurek
Journal:  Rev Physiol Biochem Pharmacol       Date:  2016       Impact factor: 5.545

4.  The PI3K/Akt, p38MAPK, and JAK2/STAT3 signaling pathways mediate the protection of SO2 against acute lung injury induced by limb ischemia/reperfusion in rats.

Authors:  Yan-Rui Zhao; Dong Wang; Yang Liu; Lei Shan; Jun-Lin Zhou
Journal:  J Physiol Sci       Date:  2015-11-05       Impact factor: 2.781

5.  Role of carbonyl sulfide in acute lung injury following limb ischemia/reperfusion in rats.

Authors:  Yan-Rui Zhao; Wen-Rui Lv; Jun-Lin Zhou
Journal:  Eur J Med Res       Date:  2017-03-28       Impact factor: 2.175

6.  The ERK1/2 signaling pathway is involved in sulfur dioxide preconditioning-induced protection against cardiac dysfunction in isolated perfused rat heart subjected to myocardial ischemia/reperfusion.

Authors:  Pan Huang; Yan Sun; Jinyan Yang; Siyao Chen; Angie Dong Liu; Lukas Holmberg; Xiaomei Huang; Chaoshu Tang; Junbao Du; Hongfang Jin
Journal:  Int J Mol Sci       Date:  2013-11-08       Impact factor: 5.923

7.  Response to thrombolytic agents in acute myocardial infarction in opium abusers versus non-abusers.

Authors:  Seyed Mohammad Hashemi Jazi; Idin Ahang Nazary; Mohaddeseh Behjati
Journal:  J Res Pharm Pract       Date:  2012-07

8.  Delay in coronary artery bypass grafting for STEMI patients improves hospital morbidity and mortality.

Authors:  Anthony Lemaire; Tudor Vagaonescu; Hirohisa Ikegami; Lindsay Volk; Nina Verghis; Leonard Y Lee
Journal:  J Cardiothorac Surg       Date:  2020-05-12       Impact factor: 1.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.